Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy
复制标题
DOI:
10.1093/brain/awm156
复制
发表时间:
2007-09-01
期刊:
影响因子:
14.5
通讯作者:
Ayata, Cenk
中科院分区:
文献类型:
--
作者:
Shin, Hwa Kyoung;Jones, Phillip B.;Ayata, Cenk
The Tg2576 transgenic mouse model of human cerebral amyloid angiopathy is characterized by age-dependent cerebrovascular deposition of amyloid-beta ( Ab) starting from 9 months of age and progressively worsening to involve most pial arterioles by 18 months; soluble A beta levels are elevated long before vascular deposition takes place in this model. It has been suggested that elevated soluble A beta levels alone are sufficient to impair cerebral blood flow (CBF) regulation thereby contributing to the early progression of Alzheimer's disease. Using laser speckle flowmetry through an intact skull, we studied the impact of elevated soluble A beta levels and vascular A beta deposition on a wide range of CBF responses to evaluate vasodilation and vasoconstriction in young or aged Tg2576 mice. Nineteen-month-old Tg2576 with severe vascular A beta deposits showed an attenuated hyperaemic response during hypercapnia and whisker stimulation compared to wild-type littermates. The anticipated increase in CBF due to isoflurane anaesthesia was also suppressed, as were the typical hypoperfusion responses during cortical spreading depression and alpha-chloralose anaesthesia. The responses of 8-month-old Tg2576 with elevated soluble A beta levels, but without vascular Ab deposition, did not differ fromage-matched controls. In conclusion, our data suggest that vascular A beta deposition is associated with impaired vasodilator as well as vasoconstrictor responses to a wide range of stimuli. These responses do not differ from controls when studied non-invasively prior to vascular A beta deposition, thus challenging the view that elevated soluble A beta levels are sufficient to cause cerebrovascular dysfunction.